Found: 287
Select item for more details and to access through your institution.
Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2133, doi. 10.1093/neuonc/noac143
- By:
- Publication type:
- Article
promising preclinical model for TERT promoter mutation in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2076, doi. 10.1093/neuonc/noac167
- By:
- Publication type:
- Article
EV packing allows meningioma tracking in blood.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2091, doi. 10.1093/neuonc/noac230
- By:
- Publication type:
- Article
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2015, doi. 10.1093/neuonc/noac188
- By:
- Publication type:
- Article
Does increase of symptoms mean progression?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2170, doi. 10.1093/neuonc/noac218
- By:
- Publication type:
- Article
Corrigendum to: Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics.
- Published in:
- 2022
- Publication type:
- Correction Notice
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2222, doi. 10.1093/neuonc/noac240
- Publication type:
- Article
FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2107, doi. 10.1093/neuonc/noac156
- By:
- Publication type:
- Article
EGFR, the Lazarus target for precision oncology in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2035, doi. 10.1093/neuonc/noac204
- By:
- Publication type:
- Article
comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2146, doi. 10.1093/neuonc/noac136
- By:
- Publication type:
- Article
Diagnostic potential of extracellular vesicles in meningioma patients.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2078, doi. 10.1093/neuonc/noac127
- By:
- Publication type:
- Article
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2180, doi. 10.1093/neuonc/noac126
- By:
- Publication type:
- Article
Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2172, doi. 10.1093/neuonc/noac125
- By:
- Publication type:
- Article
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2190, doi. 10.1093/neuonc/noac123
- By:
- Publication type:
- Article
Limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: long-term results from the RT1 protocol.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2200, doi. 10.1093/neuonc/noac124
- By:
- Publication type:
- Article
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2063, doi. 10.1093/neuonc/noac080
- By:
- Publication type:
- Article
Endocrine outcomes after limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: Long-term results from the RT1 protocol.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2210, doi. 10.1093/neuonc/noac115
- By:
- Publication type:
- Article
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2159, doi. 10.1093/neuonc/noac097
- By:
- Publication type:
- Article
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell–mediated toxicity against glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2093, doi. 10.1093/neuonc/noac107
- By:
- Publication type:
- Article
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2121, doi. 10.1093/neuonc/noac111
- By:
- Publication type:
- Article
Abstracts from the 2022 Society for Neuro-Oncology's 27<sup>th</sup> Annual Scientific Meeting and Education Day.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. vii1, doi. 10.1093/neuonc/noac209
- Publication type:
- Article
Laser hyperthermia: Past, present, and future.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S42, doi. 10.1093/neuonc/noac208
- By:
- Publication type:
- Article
Turning on the light for brain tumor surgery: A 5-aminolevulinic acid story.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S52, doi. 10.1093/neuonc/noac191
- By:
- Publication type:
- Article
Updates in intraoperative strategies for enhancing intra-axial brain tumor control.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S33, doi. 10.1093/neuonc/noac170
- By:
- Publication type:
- Article
Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S4, doi. 10.1093/neuonc/noac133
- By:
- Publication type:
- Article
Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S16, doi. 10.1093/neuonc/noac130
- By:
- Publication type:
- Article
Corrigendum to: TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.
- Published in:
- 2022
- Publication type:
- Correction Notice
Spinal brachytherapy.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S62, doi. 10.1093/neuonc/noac094
- By:
- Publication type:
- Article
Novel intraoperative strategies for enhancing tumor control: Future directions.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S25, doi. 10.1093/neuonc/noac090
- By:
- Publication type:
- Article
Society News.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 2013, doi. 10.1093/neuonc/noac228
- Publication type:
- Article
Radiation's formulations.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S1, doi. 10.1093/neuonc/noac095
- By:
- Publication type:
- Article
Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 2005, doi. 10.1093/neuonc/noac190
- By:
- Publication type:
- Article
Erratum to: Environmental and sex-specific molecular signatures of glioma causation.
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum to: A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.
- Published in:
- 2022
- Publication type:
- Correction Notice
Hurdling over the blood–brain barrier with exosome technology.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1884, doi. 10.1093/neuonc/noac214
- By:
- Publication type:
- Article
fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Targeting neddylation in cancer.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1869, doi. 10.1093/neuonc/noac159
- By:
- Publication type:
- Article
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1845, doi. 10.1093/neuonc/noac165
- By:
- Publication type:
- Article
BRAF inhibitors in BRAFV600E-mutated pediatric high-grade gliomas: Upfront or at recurrence?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1976, doi. 10.1093/neuonc/noac160
- By:
- Publication type:
- Article
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1827, doi. 10.1093/neuonc/noac146
- By:
- Publication type:
- Article
Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 2001, doi. 10.1093/neuonc/noac172
- By:
- Publication type:
- Article
Investigational PET tracers in neuro-oncology—What's on the horizon? A report of the PET/RANO group.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1815, doi. 10.1093/neuonc/noac131
- By:
- Publication type:
- Article
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1898, doi. 10.1093/neuonc/noac112
- By:
- Publication type:
- Article
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1935, doi. 10.1093/neuonc/noac116
- By:
- Publication type:
- Article
CNS non-germinomatous germ cell tumor (NGGCT): Lessons from the recent past.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1962, doi. 10.1093/neuonc/noac119
- By:
- Publication type:
- Article
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1978, doi. 10.1093/neuonc/noac109
- By:
- Publication type:
- Article
Erratum to: Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.
- Published in:
- 2022
- Publication type:
- Correction Notice
MEOX2 homeobox gene promotes growth of malignant gliomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1911, doi. 10.1093/neuonc/noac110
- By:
- Publication type:
- Article
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1989, doi. 10.1093/neuonc/noac113
- By:
- Publication type:
- Article
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1886, doi. 10.1093/neuonc/noac108
- By:
- Publication type:
- Article